5-fluorouracil-hyaluronic acid complex

Drug Profile

5-fluorouracil-hyaluronic acid complex

Alternative Names: 5-fluorouracil hyaluronan acid complex; HA-5-fluorouracil; HA-5FU; Hyaluronan acid-5-fluorouracil complex; Hyaluronic acid-5-fluorouracil complex

Latest Information Update: 01 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alchemia
  • Class Antineoplastics; Pyrimidinones; Small molecules
  • Mechanism of Action Thymidylate synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Colorectal cancer

Most Recent Events

  • 01 Dec 2015 Phase-I/II clinical trials in Colorectal cancer in Australia (IV) prior to December 2015
  • 01 Dec 2015 Efficacy and adverse event data from a phase I/II trial released by Alchemia (Alchemia pipeline, December 2015) prior to December 2015
  • 30 May 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top